CNTX
CNTX
NASDAQ · Pharmaceuticals

Context Therapeutics Inc

$0.58
+0.01 (+1.27%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +3,959.7% upside
Low Target $16.27
Average Target $23.68
High Target $31.54
Current Price $0.58
Current
$0.58
Target
$23.68
$16.27 $23.68 avg $31.54
Scenario Analysis
Bear Case
$16.27
2,689.3%
Low target
Base Case
$23.68
+3,959.7%
Avg target
Bull Case
$31.54
+5,307.2%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$3.62
-83.9% from high
52-Week Low
$0.56
+4.2% from low
Target vs 52W High
$23.68
+554.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +18.3%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +22.2%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +27.7%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +42.3%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +170.3%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%